Taken together, these data suggest that FZD2 blockade reduces tumor growth and tumor cell proliferation associated with decreased β-catenin levels and reduced angiogenesis in both, MYCN-unamplified SK-N-AS and MYCN-amplified SK-N-DZ NBs. This evidence concerns the gene MYCN and neoplasm.